On December 8, 2022, Ron Price notified Accelerate Diagnostics, Inc. (Company) of his decision to retire as the Companyâs Chief Commercial Officer, Americas. Mr. Priceâs last day with the Company is expected to be on January 6, 2023. Mr. Priceâs retirement is for personal reasons and is not the result of any disagreement with the Company on any matter relating to the Companyâs operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 USD | -3.31% | -20.41% | -70.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.15% | 27.39M | |
+7.32% | 217B | |
+13.83% | 195B | |
+20.48% | 144B | |
+31.33% | 112B | |
+3.08% | 65.83B | |
+14.64% | 52.67B | |
+2.72% | 49.86B | |
-5.88% | 38.18B | |
+0.25% | 35.39B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. Announces Resignation of Ron Price as Chief Commercial Officer